MSD has released a new ad campaign via Paper + Spark showing the many varied emotions people can face when dealing with COVID, with the news that medication to combat COVID is now available to those ...
Oxford, UK-based Adaptimmune has formed a clinical trial pact with MSD to test a potential new combination therapy for multiple myeloma. Oxford, UK-based Adaptimmune has formed a clinical trial pact ...
French pharma will test investigational candidate alongside MSD’s Keytruda Sanofi has entered an agreement with MSD – known as Merck & Co in the US – to collaborate on a phase II trial evaluating its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback